On Monday, 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) opened lower -8.61% from the last session, before settling in for the closing price of $0.14. Price fluctuations for SXTP have ranged from $0.13 to $2.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 2.28% over the past five years. Company’s average yearly earnings per share was noted 62.07% at the time writing. With a float of $15.43 million, this company’s outstanding shares have now reached $20.21 million.
Let’s look at the performance matrix of the company that is accounted for 3 employees.
60 Degrees Pharmaceuticals Inc (SXTP) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of 60 Degrees Pharmaceuticals Inc is 23.67%, while institutional ownership is 1.95%. The most recent insider transaction that took place on Jan 31 ’24, was worth 75,000. In this transaction Director of this company bought 200,000 shares at a rate of $0.38, taking the stock ownership to the 424,934 shares. Before that another transaction happened on Jan 31 ’24, when Company’s President and CEO bought 25,974 for $0.38, making the entire transaction worth $9,740. This insider now owns 703,599 shares in total.
60 Degrees Pharmaceuticals Inc (SXTP) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 3/31/2024, the company posted 0.77 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at 0.95) by -0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 62.07% per share during the next fiscal year.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
Check out the current performance indicators for 60 Degrees Pharmaceuticals Inc (SXTP). In the past quarter, the stock posted a quick ratio of 6.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.17, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of 60 Degrees Pharmaceuticals Inc (SXTP)
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) saw its 5-day average volume 1.67 million, a negative change from its year-to-date volume of 2.35 million. As of the previous 9 days, the stock’s Stochastic %D was 10.39%. Additionally, its Average True Range was 0.04.
During the past 100 days, 60 Degrees Pharmaceuticals Inc’s (SXTP) raw stochastic average was set at 4.30%, which indicates a significant increase from 4.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 134.89% in the past 14 days, which was higher than the 99.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2499, while its 200-day Moving Average is $0.4354. Nevertheless, the first resistance level for the watch stands at $0.1332 in the near term. At $0.1422, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.1574. If the price goes on to break the first support level at $0.1090, it is likely to go to the next support level at $0.0938. Assuming the price breaks the second support level, the third support level stands at $0.0848.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Key Stats
There are currently 12,206K shares outstanding in the company with a market cap of 2.51 million. Presently, the company’s annual sales total 250 K according to its annual income of -3,770 K. Last quarter, the company’s sales amounted to 150 K and its income totaled 430 K.
